Literature DB >> 26829956

Vasodilator stress agents for myocardial perfusion imaging.

Rayan Saab1, Fadi G Hage2,3.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26829956     DOI: 10.1007/s12350-016-0408-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  28 in total

1.  Adenosine 5'-triphosphate induced dilation of human coronary microvessels in vivo.

Authors:  M Kato; N Shiode; H Teragawa; H Hirao; T Yamada; T Yamagata; H Matsuura; G Kajiyama
Journal:  Intern Med       Date:  1999-04       Impact factor: 1.271

2.  Effects of intravenous and intracoronary adenosine 5'-triphosphate as compared with adenosine on coronary flow and pressure dynamics.

Authors:  A Jeremias; S D Filardo; R J Whitbourn; R S Kernoff; A C Yeung; P J Fitzgerald; P G Yock
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

3.  2013 American Society of Nuclear Cardiology / MedAxiom Nuclear Survey.

Authors: 
Journal:  J Nucl Cardiol       Date:  2014-04       Impact factor: 5.952

4.  Regadenoson for myocardial perfusion imaging: Is it safe?

Authors:  Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952

5.  The prognostic value of regadenoson myocardial perfusion imaging.

Authors:  Fadi G Hage; Gopal Ghimire; Davis Lester; Joshua Mckay; Steven Bleich; Stephanie El-Hajj; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2015-02-14       Impact factor: 5.952

6.  Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

Authors:  Ami E Iskandrian; Timothy M Bateman; Luiz Belardinelli; Brent Blackburn; Manuel D Cerqueira; Robert C Hendel; Hsiao Lieu; John J Mahmarian; Ann Olmsted; S Richard Underwood; João Vitola; Whedy Wang
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

7.  Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

Authors:  Manuel D Cerqueira; Patricia Nguyen; Peter Staehr; S Richard Underwood; Ami E Iskandrian
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

Review 8.  Regadenoson: a new myocardial stress agent.

Authors:  Wael Al Jaroudi; Ami E Iskandrian
Journal:  J Am Coll Cardiol       Date:  2009-09-22       Impact factor: 24.094

9.  Asystole following regadenoson infusion in stable outpatients.

Authors:  Jeffrey Rosenblatt; Deirdre Mooney; Timothy Dunn; Mylan Cohen
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

Review 10.  Risk stratification for coronary artery disease using pharmacological stress tests.

Authors:  Stephanie El-Hajj; Fadi G Hage
Journal:  J Med Liban       Date:  2014 Apr-Jun
View more
  5 in total

1.  Effect of aminophylline administration on the diagnostic yield of vasodilator myocardial perfusion imaging.

Authors:  Hussein Abu Daya; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-06-03       Impact factor: 5.952

Review 2.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

Review 3.  [Beyond Coronary CT Angiography: CT Fractional Flow Reserve and Perfusion].

Authors:  Moon Young Kim; Dong Hyun Yang; Ki Seok Choo; Whal Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-01-21

Review 4.  Coronary Microvascular Dysfunction: A Practical Approach to Diagnosis and Management.

Authors:  Daria Frestad Bechsgaard; Eva Prescott
Journal:  Curr Atheroscler Rep       Date:  2021-07-16       Impact factor: 5.113

Review 5.  Computed tomographic evaluation of myocardial ischemia.

Authors:  Yuki Tanabe; Akira Kurata; Takuya Matsuda; Kazuki Yoshida; Dhiraj Baruah; Teruhito Kido; Teruhito Mochizuki; Prabhakar Rajiah
Journal:  Jpn J Radiol       Date:  2020-02-05       Impact factor: 2.374

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.